Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model

Blood Cells, Molecules, and Diseases

Volumn 35, Issue 3, 2005, Pages 348-354

  Lamghari, M ^a   Barrias, C C ^a   Sa Miranda C ^b   Barbosa, M A ^a  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Enzyme uptake; Gaucher disease; Glucocerebrosidase; Osteoblasts

Indexed keywords

CELL EXTRACT; CONDURITOL B EPOXIDE; ENZYME ANTIBODY; EPOXIDE; IMIGLUCERASE; IODINE 125; MANNOSE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; GAUCHER DISEASE; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; OSTEOBLAST; PRIORITY JOURNAL; WESTERN BLOTTING;

CELLS, CULTURED; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; INOSITOL; OSTEOBLASTS; RECOMBINANT PROTEINS;

EID: 27744461413     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.07.009     Document Type: Article

References (34)

1. E. Beutler, and G. Grabowski Gaucher disease C.R. Scriber A.L. Beaudet W.S. Sly 7th ed. The Metabolic and Molecular Bases of Inherited Disease vol. 2 1995 McGraw-Hill New York, NY 2641 2661
2. E. Beutler Enzyme replacement in Gaucher disease PLoS Med. 1 2 2004 e21
3. D. Elstein, M. Itzchaki, and H. Mankin Skeletal involvement in Gaucher's disease Ballière's Clin. Haematol. 10 4 1997 793 815
4. R.J. Wenstrup, M. Roca-Espiau, N.J. Weinreb, and B. Bembi Skeletal aspects of Gaucher disease: a review Br. J. Radiol. 75 Suppl. 1 2002 A2 A12
5. J.A. Barranger, and E. O'Rourke Lessons learned from the development of enzyme therapy for Gaucher disease J. Inherited Metab. Dis. 24 Suppl. 2 2001 89 96
6. A. Zimran, D. Elstein, E. Levy-Lahad, S. Zevin, I. Hadas-Halpern, Y. Bar-Ziv, J. Foldes, A.J. Schwartz, and A. Abrahamov Replacement therapy with imiglucerase for type 1 Gaucher's disease Lancet 345 8963 1995 1479 1480
7. N.W. Barton, R.O. Brady, J.M. Dambrosia, AM. Di Bisceglie, S.H. Doppelt, S.C. Hill, H.J. Mankin, G.J. Murray, R.I. Parker, and C.E. Argoff Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease N. Engl. J. Med. 324 21 1991 1464 1470
8. N.W. Barton, F.S. Furbish, G.J. Murray, M. Garfield, and R.O. Brady Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease Proc. Natl. Acad. Sci. U. S. A. 87 5 1990 1913 1916
9. B. Friedman, K. Vaddi, C. Preston, E. Mahon, J.R. Cataldo, and J.M. McPherson A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease Blood 93 1999 2807 2816
10. G.A. Grabowski, N. Leslie, and R. Wenstrup Enzyme therapy for Gaucher disease: the first 5 years Blood Rev. 12 2 1998 115 133
11. R. Samuel, K. Katz, S.E. Papapoulos, Z. Yosipovitch, R. Zaizov, and U.A. Liberman Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease Pediatrics 94 3 1994 385 389
12. R. Shiffmann, H. Mankin, J.M. Dambrosia, R.J. Xavier, C. Kreps, S.C. Hills, N.W. Barton, and D.I. Rosenthal Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy Blood Cells Mol. Dis. 28 2002 288 296
13. Iodine-125, A Guide to Radioiodination 1993 Amersham Life Science 64
14. C.C. Barrias, M.C.L. Martins, M.C. Sá Miranda, and M.A. Barbosa Adsorption of a therapeutic enzyme to self-assembled monolayers: effect of surface chemistry and solution pH on the amount and activity of adsorbed enzyme Biomaterials 26 2005 2695 2704
15. U.K. Laemmli Nature 227 1970 680 685
16. M.C. Sá Miranda, J.M. Aerts, R. Pinto, A. Fontes, L.W. Lacerda, S. van Weely, J. Barranger, and J.M. Tager Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients Clin. Genet. 38 1990 218 227
17. C.C. Barrias, M. Lamghari, P.L. Granja, C. Sá Miranda, and M.A. Barbosa Biological evaluation of calcium alginate microspheres as a vehicle for the localised delivery of a therapeutic enzyme J. Biomed. Mater. Res. Jul. 18 2005 (Electronic publication ahead of print)
18. C.C. Barrias, C.C. Ribeiro, M. Lamghari, C. Sá Miranda, and M.A. Barbosa Proliferation, activity, and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres J. Biomed. Mater. Res. 1 72A(1) 2005 57 66
19. C.C. Ribeiro, C.C. Barrias, and M.A. Barbosa Calcium phosphate-alginate microspheres as enzyme delivery matrices Biomaterials 25 18 2004 4363 4373
20. P.K. Das, G.J. Murray, A.E. Gal, and J.A. Barranger Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages Exp. Cell Res. 168 2 1987 463 474
21. D. Pelled, H. Shogomori, and A.H. Futerman The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase J. Inherited Metab. Dis. 23 2 2000 175 184
22. K. Hanley, Y. Jiang, W.M. Holleran, P.M. Elias, M.L. Williams, and K.R. Feingold Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat J. Lipid Res. 38 3 1997 576 584
23. J. Marshall, KA. McEachern, J.A. Kyros, J.B. Nietupski, T. Budzinski, R.J. Ziegler, N.S. Yew, J. Sullivan, A. Scaria, N. van Rooijen, J.A. Barranger, and S.H. Cheng Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model Mol. Ther. 6 2 2002 179 189
24. P.K. Mistry, E.P. Wraight, and T.M. Cox Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease Lancet 348 9041 1996 1555 1559
25. Y.H. Xu, E. Ponce, Y. Sun, T. Leonova, K. Bove, D. Witte, and G.A. Grabowski Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues Pediatr. Res. 39 2 1996 313 322
26. E. Beutler, W. Kuhl, and L.M. Vaughan Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages Mol. Med. 1 1995 320 324
27. Y. Sato, and E. Beutler Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages J. Clin. Invest. 91 1993 1909 1917
28. U. Schueler, C. Kaneski, G. Murray, K. Sandhoff, and R.O. Brady Uptake of mannose-terminal glucocerebrosidase in cultured human cholinergic and dopaminergic neuron cell lines Neurochem. Res. 27 4 2002 325 330
29. F.S. Furbish, C.J. Steer, J.A. Barranger, E.A. Jones, and R.O. Brady The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells Biochem. Biophys. Res. Commun. 81 1978 1047 1053
30. F.S. Furbish, C.J. Steer, N.L. Krett, and J.A. Barranger Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation Biochim. Biophys. Acta 673 1981 425 434
31. L. East, and C.M. Isacke The mannose receptor family Biochim. Biophys. Acta. 1572 2002 364 386
32. L. East, S. Rushton, M.E. Taylor, and C.M. Isack Characterization of sugar binding by the mannose receptor family member, Endo180 J. Biol. Chem. 277 52 2002 50469 50475
33. L.H. Engelholm, B.S. Nielsen, S. Netzel-Arnett, H. Solberg, X.D. Chen, J.M. Lopez Garcia, C. Lopez-Otin, M.F. Young, H. Birkedal-Hansen, K. Dano, L.R. Lund, N. Behrendt, and T.H. Bugge The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis Lab. Invest. 81 2001 1403 1414
34. L. Bailey, D. Wienke, M. Howard, V. Knauper, C.M. Isacke, and G. Murphy Investigation of the role of Endo180/urokinase-type plasminogen activator receptor-associated protein as a collagenase 3 (matrix metalloproteinase 13) receptor Biochem. J. 1 363(Pt. 1) 2002 67 72